1. PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity;Logan;Anticancer Res,2013
2. Iclusig (ponatinib) [prescribing information],2014
3. Sprycel (dasatinib) [prescribing information],2015
4. Gleevec (imatinib mesylate) [prescribing information],2015
5. BOSULIF (bosutinib) [prescribing information],2016